Tanvex BioPharma Revenue

Tanvex BioPharma had revenue of 49.86M TWD in the quarter ending March 31, 2025, with 1,385.31% growth. This brings the company's revenue in the last twelve months to 81.18M, up 134.43% year-over-year. In the year 2024, Tanvex BioPharma had annual revenue of 34.68M, down -43.53%.

Revenue (ttm)

81.18M

Revenue Growth

+134.43%

P/S Ratio

147.18

Revenue / Employee

410.02K

Employees

198

Market Cap

11.95B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	34.68M	-26.73M	-43.53%
Dec 31, 2023	61.41M	39.01M	174.11%
Dec 31, 2022	22.40M	17.00M	314.43%
Dec 31, 2021	5.41M	5.11M	1,702.00%
Dec 31, 2020	300.00K	-	-
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Caliway Biopharmaceuticals	40.47M
PharmaEssentia	11.34B
Bora Pharmaceuticals Co., LTD.	20.87B
Lotus Pharmaceutical	19.12B
Oneness Biotech	117.33M
Polaris Group	87.67M
Center Laboratories	1.63B
Lumosa Therapeutics	43.59M

Revenue Rankings